Rv1630 - p.Glu168Lys
Drug resistance types
0 Sensitive
9 RR-TB
0 HR-TB
7 MDR-TB
8 Pre-XDR-TB
1 XDR-TB
1 Other
lineage Counts
| lineage | Count |
|---|---|
| lineage2.2.1 | 1 |
| lineage2.2.2 | 13 |
| lineage4.9 | 5 |
| lineage4.2.1 | 2 |
| La1.7.X-unk4 | 1 |
| lineage3 | 1 |
| lineage4.4.1.1 | 1 |
| lineage3.1.2.1 | 1 |
| lineage2.2;lineage4 | 1 |
spoligotype Counts
| spoligotype | Count |
|---|---|
| None | 26 |
Geographic prevalence
Country level data for this variant is available for 0 isolates.
Variant Proportion
Hover over a Country 0–0.1
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
0.1–0.2
0.2–0.3
0.3–0.4
0.4–0.5
0.5–0.6
0.6–0.8
0.8+
Statisctical support
Not enough data to calculate support.
Samples
| ID | Drug resistance | Lineage | Country iso2 |
|---|---|---|---|
| SRR16156697 | RR-TB | lineage2.2.1 | None |
| ERR4811158 | Pre-XDR-TB | lineage2.2.2 | cn |
| SRR6824594 | Pre-XDR-TB | lineage2.2.2 | cn |
| ERR3283006 | RR-TB | lineage4.9 | None |
| SRR8651647 | MDR-TB | lineage2.2.2 | cn |
| ERR502946 | Pre-XDR-TB | lineage2.2.2 | None |
| ERR10762275 | MDR-TB | lineage4.2.1 | None |
| ERR4810480 | MDR-TB | lineage2.2.2 | cn |
| SRR1723426 | Pre-XDR-TB | lineage2.2.2 | cn |
| SRR25207195 | Pre-XDR-TB | lineage2.2.2 | None |
| SRR10305976 | Pre-XDR-TB | lineage2.2.2 | None |
| ERR3445487 | Other | La1.7.X-unk4 | None |
| ERR502470 | RR-TB | lineage4.9 | None |
| SRR5341365 | Pre-XDR-TB | lineage3 | None |
| ERR4769530 | RR-TB | lineage4.9 | None |
| SRR25207200 | MDR-TB | lineage2.2.2 | None |
| ERR4810845 | MDR-TB | lineage2.2.2 | cn |
| SRR25207084 | Pre-XDR-TB | lineage2.2.2 | None |
| ERR4811320 | XDR-TB | lineage2.2.2 | cn |
| ERR3797062 | RR-TB | lineage4.9 | None |
| SRR17567917 | RR-TB | lineage4.4.1.1 | None |
| SRR14782539 | MDR-TB | lineage4.2.1 | None |
| SRR25207087 | MDR-TB | lineage2.2.2 | None |
| ERR4816717 | RR-TB | lineage3.1.2.1 | None |
| SRR16156832 | RR-TB | lineage2.2;lineage4 | None |
| ERR4769508 | RR-TB | lineage4.9 | None |
